The toxic effect of MGO has been extensively studied mostly in diabetic settings, especially its involvement in inducing diabetic sensorimotor polyneuropathy (DSPN), neuropathic pain, endothelial dysfunction, and functional alterations of human insulin. The gene discussed is INS; the disease is endothelial dysfunction.